Document Detail


Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study.
MedLine Citation:
PMID:  20299513     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Patients with multiple myeloma (MM) have an increased risk of venous thrombosis. Interestingly, excess risk of venous thromboembolism has been observed among patients with monoclonal gammopathy of undetermined significance (MGUS). Using population-based data from Sweden, we assessed the risks of venous and arterial thrombosis in 18,627 MM and 5326 MGUS patients diagnosed from 1958 to 2006, compared with 70,991 and 20,161 matched controls, respectively. At 1, 5, and 10 years after MM diagnosis, there was an increased risk of venous thrombosis: hazard ratios (95% confidence intervals) were 7.5 (6.4-8.9), 4.6 (4.1-5.1), and 4.1 (3.8-4.5), respectively. The corresponding results for arterial thrombosis were 1.9 (1.8-2.1), 1.5 (1.4-1.6), and 1.5 (1.4-1.5). At 1, 5, and 10 years after MGUS diagnosis, hazard ratios were 3.4 (2.5-4.6), 2.1 (1.7-2.5), and 2.1 (1.8-2.4) for venous thrombosis. The corresponding risks for arterial thrombosis were 1.7 (1.5-1.9), 1.3 (1.2-1.4), and 1.3 (1.3-1.4). IgG/IgA (but not IgM) MGUS patients had increased risks for venous and arterial thrombosis. Risks for thrombosis did not vary by M-protein concentration (> 10.0 g/L or < 10.0 g/L) at diagnosis. MGUS patients with (vs without) thrombosis had no excess risk of MM or Waldenström macroglobulinemia. Our findings are of relevance for future studies and for improvement of thrombosis prophylaxis strategies.
Authors:
Sigurdur Y Kristinsson; Ruth M Pfeiffer; Magnus Björkholm; Lynn R Goldin; Sam Schulman; Cecilie Blimark; Ulf-Henrik Mellqvist; Anders Wahlin; Ingemar Turesson; Ola Landgren
Related Documents :
11418373 - Inherited thrombophilic risk factors in a large cohort of individuals referred to itali...
868473 - The arterial angioarchitecture of cerebral infarctions.
906063 - Angiographic spectrum of cervical and intracranial fibromuscular dysplasia.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't     Date:  2010-03-18
Journal Detail:
Title:  Blood     Volume:  115     ISSN:  1528-0020     ISO Abbreviation:  Blood     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-06-18     Completed Date:  2010-07-09     Revised Date:  2011-08-01    
Medline Journal Info:
Nlm Unique ID:  7603509     Medline TA:  Blood     Country:  United States    
Other Details:
Languages:  eng     Pagination:  4991-8     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, Division of Hematology, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden. sigurdur.kristinsson@karolinska.se
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Arteries
Databases, Factual
Female
Humans
Immunoglobulin A / blood
Immunoglobulin G / blood
Male
Middle Aged
Multiple Myeloma / blood,  mortality*
Paraproteinemias / blood,  mortality*
Predictive Value of Tests
Proportional Hazards Models
Registries
Risk Factors
Survival Analysis
Sweden / epidemiology
Veins
Venous Thrombosis / blood,  mortality*,  prevention & control
Waldenstrom Macroglobulinemia / blood,  mortality
Chemical
Reg. No./Substance:
0/Immunoglobulin A; 0/Immunoglobulin G
Comments/Corrections
Comment In:
Blood. 2010 Jun 17;115(24):4975-6   [PMID:  20558621 ]
Erratum In:
Blood. 2011 Apr 7;117(14):3938

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Members of the microRNA-17-92 cluster exhibit a cell intrinsic anti-angiogenic function in endotheli...
Next Document:  E-selectin engages PSGL-1 and CD44 through a common signaling pathway to induce integrin alphaLbeta2...